$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf

$anf Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000101884015000036 Filed on June 08, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$709.4M	$822.4M
YoY Change	-13.74%	-1.95%
Cost Of Revenue	$297.9M	$310.8M
YoY Change	-4.15%	8.81%
Gross Profit	$411.5M	$511.7M
YoY Change	-19.57%	-7.5%
Gross Profit Margin	58.01%	62.21%
Selling, General & Admin	$499.2M	$541.2M
YoY Change	-7.76%	-4.7%
% of Gross Profit	121.3%	105.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$53.30M	$58.90M
YoY Change	-9.51%	-1.01%
% of Gross Profit	12.95%	11.51%
Operating Expenses	$497.4M	$536.8M
YoY Change	-7.34%	-5.58%
Operating Profit	-$90.20M	-$31.51M
YoY Change	186.29%	126.32%
Interest Expense	-$4.400M	$1.300M
YoY Change	-438.46%	30.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$94.84M	-$33.50M
YoY Change	183.07%	115.47%
Income Tax	-$31.59M	-$9.832M
% Of Pretax Income
Net Earnings	-$63.25M	-$23.67M
YoY Change	167.19%	228.63%
Net Earnings / Revenue	-8.92%	-2.88%
Basic Earnings Per Share	-$0.91	-$0.32
Diluted Earnings Per Share	-$0.91	-$0.32
COMMON SHARES
Basic Shares Outstanding	69.51M shares	74.48M shares
Diluted Shares Outstanding	69.51M shares	74.48M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$383.2M	$357.1M
YoY Change	7.31%	-35.76%
Cash & Equivalents	$408.3M	$357.1M
Short-Term Investments
Other Short-Term Assets	$118.6M	$103.1M
YoY Change	14.97%	-9.66%
Inventory	$441.0M	$486.0M
Prepaid Expenses
Receivables	$59.20M	$70.00M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.047B	$1.053B
YoY Change	-0.6%	-16.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$949.6M	$1.122B
YoY Change	-15.35%	-11.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$368.3M	$391.6M
YoY Change	-5.96%	7.28%
Total Long-Term Assets	$1.318B	$1.513B
YoY Change	-12.92%	-7.34%
TOTAL ASSETS
Total Short-Term Assets	$1.047B	$1.053B
Total Long-Term Assets	$1.318B	$1.513B
Total Assets	$2.365B	$2.566B
YoY Change	-7.86%	-11.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$122.8M	$122.1M
YoY Change	0.56%	-16.53%
Accrued Expenses	$280.0M	$282.9M
YoY Change	-1.02%	-6.17%
Deferred Revenue
YoY Change
Short-Term Debt	$2.017M	$15.00M
YoY Change	-86.55%	0.0%
Long-Term Debt Due	$2.000M	$15.00M
YoY Change	-86.67%	0.0%
Total Short-Term Liabilities	$437.5M	$470.1M
YoY Change	-6.93%	-11.88%
LONG-TERM LIABILITIES
Long-Term Debt	$290.3M	$116.3M
YoY Change	149.75%	-11.43%
Other Long-Term Liabilities	$177.3M	$228.2M
YoY Change	-22.29%	0.13%
Total Long-Term Liabilities	$619.8M	$543.7M
YoY Change	14.0%	-6.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$437.5M	$470.1M
Total Long-Term Liabilities	$619.8M	$543.7M
Total Liabilities	$1.057B	$1.014B
YoY Change	4.29%	-9.1%
SHAREHOLDERS EQUITY
Retained Earnings	$2.473B	$2.518B
YoY Change	-1.77%	-0.98%
Common Stock	$423.7M	$424.5M
YoY Change	-0.19%	5.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.501B	$1.381B
YoY Change	8.7%	20.4%
Treasury Stock Shares	33.74M shares	30.53M shares
Shareholders Equity	$1.307B	$1.553B
YoY Change
Total Liabilities & Shareholders Equity	$2.365B	$2.566B
YoY Change	-7.86%	-11.35%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$63.25M	-$23.67M
YoY Change	167.19%	228.63%
Depreciation, Depletion And Amortization	$53.30M	$58.90M
YoY Change	-9.51%	-1.01%
Cash From Operating Activities	-$93.78M	-$40.14M
YoY Change	133.64%	-72.05%
INVESTING ACTIVITIES
Capital Expenditures	$29.92M	$37.83M
YoY Change	-20.92%	-10.72%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$29.92M	-$37.83M
YoY Change	-20.92%	-15.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$150.0M
YoY Change	-100.0%	819.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$14.61M	-$171.7M
YoY Change	-91.49%	-258.58%
NET CHANGE
Cash From Operating Activities	-$93.78M	-$40.14M
Cash From Investing Activities	-$29.92M	-$37.83M
Cash From Financing Activities	-$14.61M	-$171.7M
Net Change In Cash	-$138.3M	-$249.7M
YoY Change	-44.6%	210.64%
FREE CASH FLOW
Cash From Operating Activities	-$93.78M	-$40.14M
Capital Expenditures	$29.92M	$37.83M
Free Cash Flow	-$123.7M	-$77.97M
YoY Change	58.65%	-58.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	anf	Additional Time Period In Which Forecasted Transaction Is Not Expected To Occur AdditionalTimePeriodInWhichForecastedTransactionIsNotExpectedToOccur	P2M
CY2014Q2	anf	Amortized Deferred Lease Credits AmortizedDeferredLeaseCredits	12005000	USD
CY2015Q2	anf	Amortized Deferred Lease Credits AmortizedDeferredLeaseCredits	7694000	USD
CY2014Q2	anf	Current Deferred Income Tax Expense Benefit CurrentDeferredIncomeTaxExpenseBenefit	17189000	USD
CY2015Q2	anf	Current Deferred Income Tax Expense Benefit CurrentDeferredIncomeTaxExpenseBenefit	31285000	USD
CY2015Q1	anf	Deferred Lease Credits Current DeferredLeaseCreditsCurrent	26629000	USD
CY2015Q2	anf	Deferred Lease Credits Current DeferredLeaseCreditsCurrent	26102000	USD
CY2015Q1	anf	Deferred Lease Credits Noncurrent DeferredLeaseCreditsNoncurrent	106393000	USD
CY2015Q2	anf	Deferred Lease Credits Noncurrent DeferredLeaseCreditsNoncurrent	102375000	USD
CY2015Q1	anf	Inventory Shrink Reserve InventoryShrinkReserve	11364000	USD
CY2015Q2	anf	Inventory Shrink Reserve InventoryShrinkReserve	15219000	USD
CY2015Q1	anf	Leasehold Financing Obligation LeaseholdFinancingObligation	50521000	USD
CY2015Q2	anf	Leasehold Financing Obligation LeaseholdFinancingObligation	49765000	USD
CY2014Q2	anf	Lessor Construction Allowances LessorConstructionAllowances	-588000	USD
CY2015Q2	anf	Lessor Construction Allowances LessorConstructionAllowances	-370000	USD
CY2014Q2	anf	Marketing General And Administrative Expense MarketingGeneralAndAdministrativeExpense	123581000	USD
CY2015Q2	anf	Marketing General And Administrative Expense MarketingGeneralAndAdministrativeExpense	107533000	USD
CY2015Q2	anf	Maximum Length Of Time Inventory Sales Hedged MaximumLengthOfTimeInventorySalesHedged	P12M
CY2015Q2	anf	Period In Which Remaining Unrealized Gains Or Losses On Intercompany Inventory Sales Are Recognized PeriodInWhichRemainingUnrealizedGainsOrLossesOnIntercompanyInventorySalesAreRecognized	P12M
CY2015Q2	anf	Sharebased Compensation Arrangementby Sharebased Paymentaward Target Percentageof Equity Awards Earned SharebasedCompensationArrangementbySharebasedPaymentawardTargetPercentageofEquityAwardsEarned	1
CY2014Q2	anf	Stores And Distribution Expense StoresAndDistributionExpense	417571000	USD
CY2015Q2	anf	Stores And Distribution Expense StoresAndDistributionExpense	391638000	USD
CY2015Q2	dei	Amendment Flag AmendmentFlag	false
CY2015Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-30
CY2015Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q2	dei	Document Period End Date DocumentPeriodEndDate	2015-05-02
CY2015Q2	dei	Document Type DocumentType	10-Q
CY2015Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001018840
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69568798	shares
CY2015Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q2	dei	Entity Registrant Name EntityRegistrantName	ABERCROMBIE & FITCH CO /DE/
CY2015Q2	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015Q2	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	141685000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	122757000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	32804000	USD
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6642000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	282736000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	279985000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1830249000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1837369000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20917000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9180000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-83580000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-89015000	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	434137000	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	422713000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5300000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6900000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11400000	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12151000	shares
CY2014Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2015Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6133000	USD
CY2015Q1	us-gaap	Assets Assets	2505167000	USD
CY2015Q2	us-gaap	Assets Assets	2364592000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	1164972000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	1046742000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600116000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	357122000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	520708000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	383220000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-242994000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-137488000	USD
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.20
CY2015Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.20
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	1033000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	1033000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11934000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-68681000	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	310769000	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	297873000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13986000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	44785000	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58897000	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	53291000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	6663000	USD
CY2015Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	821000	USD
CY2014Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.293
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.333
CY2014Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	2000000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	2300000	USD
CY2014Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1360000	USD
CY2015Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1716000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	511659000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	411549000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-33503000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-94836000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9832000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31590000	USD
CY2014Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	57059000	USD
CY2015Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34952000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-45834000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-32909000	USD
CY2014Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-47555000	USD
CY2015Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-29495000	USD
CY2014Q2	us-gaap	Increase Decrease In Construction Payables IncreaseDecreaseInConstructionPayables	-3789000	USD
CY2015Q2	us-gaap	Increase Decrease In Construction Payables IncreaseDecreaseInConstructionPayables	8856000	USD
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45461000	USD
CY2015Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19855000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6870000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7977000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-12350000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-9397000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1997000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4639000	USD
CY2014Q2	us-gaap	Interest Paid InterestPaid	1055000	USD
CY2015Q2	us-gaap	Interest Paid InterestPaid	3832000	USD
CY2015Q1	us-gaap	Inventory Gross InventoryGross	484865000	USD
CY2015Q2	us-gaap	Inventory Gross InventoryGross	496519000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	460794000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	441005000	USD
CY2015Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12707000	USD
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	40295000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2505167000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2364592000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	485956000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	437503000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	629510000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	619789000	USD
CY2015Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	295100000	USD
CY2015Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	292500000	USD
CY2015Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	291310000	USD
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	290338000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-171688000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14609000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37829000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29917000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40140000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-93783000	USD
CY2015Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-31506000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-90197000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	116574000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	118563000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	373194000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	368263000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	9841000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	204000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-3129000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-5420000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-462000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-397000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14866000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11737000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5435000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	181286000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	177311000	USD
CY2014Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3620000	USD
CY2015Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1960000	USD
CY2014Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	150000000	USD
CY2015Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2014Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14665000	USD
CY2015Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13871000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37829000	USD
CY2015Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29917000	USD
CY2014Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3273000	USD
CY2015Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	12000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-23671000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-63246000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2797250000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2786956000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	967001000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	949587000	USD
CY2015Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	52910000	USD
CY2015Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	59169000	USD
CY2014Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-1434000	USD
CY2015Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	6036000	USD
CY2014Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3750000	USD
CY2015Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	750000	USD
CY2014Q2	us-gaap	Restructuring Charges RestructuringCharges	5633000	USD
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges	-1598000	USD
CY2014Q2	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	USD
CY2015Q2	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	6133000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2550673000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2473346000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	822428000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	709422000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5288000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	6855000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	317600	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	64.35
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10500	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	124200	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	328100	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	317600	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.64
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.35
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	73.48
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	124200	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y5M
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M
CY2015Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2102000	USD
CY2015Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	2017000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1389701000	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1307300000	USD
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	33948000	shares
CY2015Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	33743000	shares
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1512562000	USD
CY2015Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1500777000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74483000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69510000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	103300000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	103300000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74483000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69510000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	28817000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	33790000	shares
CY2015Q2	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s fiscal year ends on the Saturday closest to January 31. All references herein to “Fiscal 2015” represent the 52-week fiscal year ending on January 30, 2016; and to “Fiscal 2014” represent the 52-week fiscal year ended January 31, 2015.</font></div></div>
CY2015Q2	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a defendant in lawsuits and other adversary proceedings arising in the ordinary course of business. Legal costs incurred in connection with the resolution of claims and lawsuits are generally expensed as incurred, and the Company establishes reserves for the outcome of litigation where it deems appropriate to do so under applicable accounting rules. The Company’s assessment of the current exposure could change in the event of the discovery of additional facts with respect to legal matters pending against the Company or determinations by judges, juries, administrative agencies or other finders of fact that are not in accordance with the Company’s evaluation of claims. Actual liabilities may exceed the amounts reserved, and there can be no assurance that final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows. The Company has established accruals for certain matters where losses are deemed probable and reasonably estimable. There are other claims and legal proceedings pending against the Company for which accruals have not been established.</font></div></div>
CY2015Q2	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Business</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Abercrombie & Fitch Co. (“A&F”), through its subsidiaries (collectively, A&F and its subsidiaries are referred to as "Abercrombie & Fitch" or the “Company”), is a specialty retailer that operates stores and direct-to-consumer operations. The Company operates stores in North America, Europe, Asia and the Middle East and direct-to-consumer operations in North America, Europe and Asia that service its brands throughout the world. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0001018840-15-000036-index-headers.html	Edgar Link	pending
0001018840-15-000036-index.html	Edgar Link	pending
0001018840-15-000036.txt	Edgar Link	pending
0001018840-15-000036-xbrl.zip	Edgar Link	pending
anf-20150502.xml	Edgar Link	completed
anf-20150502.xsd	Edgar Link	pending
anf-20150502_cal.xml	Edgar Link	unprocessable
anf-20150502_def.xml	Edgar Link	unprocessable
anf-20150502_lab.xml	Edgar Link	unprocessable
anf-20150502_pre.xml	Edgar Link	unprocessable
exhibit15-awarenessletterq.htm	Edgar Link	pending
exhibit311-ceocertq12015.htm	Edgar Link	pending
exhibit312-cfocertq12015.htm	Edgar Link	pending
exhibit32-ceocfocertq12015.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
q12015form10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf

2015 Q2 Form 10-Q Financial Statement

#000101884015000036 Filed on June 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANF ABERCROMBIE & FITCH CO /DE/ Stock $anf

2015 Q2 Form 10-Q Financial Statement

#000101884015000036 Filed on June 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf